Key result
Highest CD4+CD28null T-cell levels linked to ~52% lower incidence of first-time coronary events.
Case-Control (n=745)
Answers are grounded in this paper and cite their sources.
Objective: CD4 + CD28 null T cells have been shown to be associated with recurrent coronary events and suggested as potential biomarker and therapeutic target. It is unknown whether CD4 + CD28 null T cells associate with first-time cardiovascular events. We examined CD4 + CD28 null T cells in a prospective population-based cohort and in patients with advanced atherosclerosis. Approach and Results: CD4 + CD28 null T cells were quantified in 272 individuals experiencing a first-time coronary event during up to 17 years of follow-up and 272 age- and sex-matched controls in a case-control study, nested within the population-based Malmö Diet and Cancer study. The highest tertile of CD4 + CD28 null T cells was associated with a lower incidence of first-time coronary events compared with the lowest tertile (odds ratio, 0.48 [95% CI, 0.29–0.79], P =0.004) when adjusting for Framingham risk factors. This association remained significant for events recorded after >9 years of follow-up, when most coronary events occurred, but not during the first 9 years of follow-up, despite similar odds ratio. Additionally, we analyzed CD4 + CD28 null T cells in 201 patients with advanced atherosclerosis undergoing carotid endarterectomy. The adjusted hazard ratio for cardiovascular events in patients with advanced atherosclerosis was 2.11 (95% CI, 1.10–4.05, P =0.024), comparing the highest with the lowest CD4 + CD28 null T-cell tertile. Conclusions: Our findings reveal complex associations between CD4 + CD28 null T cells and cardiovascular disease. Although we confirm the reported positive associations with an adverse prognosis in patients with already established disease, the opposite associations with first-time coronary events in the population-based cohort may limit the clinical use of CD4 + CD28 null T cells.
No takes yet. Share an insight, caveat, or question.
Tomas et al. (2019) conducted a case-control in First-time coronary events and advanced atherosclerosis (n=745). Highest tertile of CD4+CD28null T cells vs. Lowest tertile of CD4+CD28null T cells was evaluated on First-time coronary events (OR 0.48, 95% CI 0.29-0.79, p=0.004). The highest tertile of CD4+CD28null T cells was associated with a lower incidence of first-time coronary events vs the lowest tertile.
Synapse has enriched 10 related papers. Consider them for comparative context: